The trademark application LCBODY was filed by Shanghai Xuyue Biotechnology CO., LTD., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on October 5, 2022, and it was registered by office on January 12, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes
Immunostimulants
Biological preparations for medical purposes
Pharmaceutical preparations
Biological preparations for the treatment of cancer
Pharmaceutical products for the treatment of cancer
Biochemical preparations for medical use
Vitamin preparations
Tumor suppressing agents
Biological preparations for veterinary purposes
Bacteriological preparations for medical and veterinary use
Bacterial poisons
Bacterial preparations for medical and veterinary use
Drugs for medical purposes
Preparations of microorganisms for medical or veterinary use
Diagnostic preparations for medical purposes
Chemical preparations for pharmaceutical purposes
Anti-infectives
Dietetic substances adapted for medical use
Preparations for destroying noxious animals
Dressings, medical
Teeth filling material.
The mark was filed in class 42 with following description of goods:
Scientific research for medical purposes in the area of cancerous diseases
Technological research
Research and development of new products for others
Scientific laboratory services
Scientific research
Pharmaceutical drug development services
Chemistry services
Medical research
Biological research
Computer programming
Conducting technical project studies
Scientific research for medical purposes
Chemical analysis
Chemical research
Biochemical research
Analysis of the mode of action of chemical combinations on animals
Culturing of cells for scientific research purposes
Research and development of vaccines and medicines
Biotechnology research
Research and development services in the field of antibody technology.